Abstract: Photodynamic therapy( PDT) has been applied in cancer treatment by utilizing reactive oxygen species to kill cancer cells.H owever,ahigh concentration of glutathione (GSH) is present in cancer cells and can consume reactive oxygen species.T oa ddress this problem, we report the development of ap hotosensitizer-MnO 2 nanosystem for highly efficient PDT.I no ur design, MnO 2 nanosheets adsorb photosensitizer chlorin e6 (Ce6), protect it from self-destruction upon light irradiation, and efficiently deliver it into cells. The nanosystem also inhibits extracellular singlet oxygen generation by Ce6, leading to fewer side effects.O nce endocytosed, the MnO 2 nanosheets are reduced by intracellular GSH. As ar esult, the nanosystem is disintegrated, simultaneously releasing Ce6 and decreasing the level of GSH for highly efficient PDT.Moreover,fluorescence recovery,accompanied by the dissolution of MnO 2 nanosheets,c an provide af luorescence signal for monitoring the efficacy of delivery.
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Photodynamic therapy (PDT) is aclinical cancer treatment method which utilizes reactive oxygen species,such as singlet oxygen ( 1 O 2 )generated through the reaction between aphotosensitizer and tissue oxygen under illumination, to kill cancer cells.I nc omparison with traditional cancer therapy methods,s uch as surgery,c hemotherapy,a nd radiotherapy, PDT possesses several unique advantages,including minimal invasion, fewer side effects,n egligible drug resistance,a nd low minimal toxicity. [1] [2] [3] As ac onsequence,q uite af ew PDT agents (photosensitizers) that possess high 1 O 2 quantum yields with excellent photophysical properties and good biocompatibility have been discovered for cancer treatment. [4] [5] [6] [7] [8] In parallel, the search for strategies enabling efficient delivery of photosensitizers into cancer cells is ongoing. One efficient approach employs nanocarriers to deliver cancer treatment agents into cancer cells. [9] [10] [11] [12] [13] [14] [15] In the past two decades,d ifferent nanomaterials,s uch as metallic, carbon, silica, and organic polymer nanomaterials,have been developed for intracellular photosensitizer delivery. [16] [17] [18] [19] [20] [21] [22] Glutathione (GSH) is an important antioxidant and the most abundant low-molecular-weight thiol in vivo,w ith ac oncentration range from 1t o1 5mm. [23] At the same time, however, it has been shown to consume 1 O 2 generated by PDT agents,t hus greatly reducing the efficiencyo fP DT and limiting the clinical applications of current PDT agents. [24] [25] [26] Therefore,the development of amultifunctional nanosystem which can both enhance the cellular uptake of photosensitizers and decrease the level of GSH in cancer cells in situ is highly desired.
MnO 2 nanosheets,w hich are ultrathin semiconductors, have attracted extensive attention in bioanalysis,cell imaging, and drug delivery. [27] [28] [29] [30] [31] They exhibit several unique features favorable for the delivery of photosensitizers with enhanced PDT efficiency. First, MnO 2 nanosheets can strongly adsorb small organic molecules,such as photosensitizers,byelectrostatic interaction and Mn À Nc oordinate bonds,w hich can facilitate their endocytosisf or intracellular PDT. [28] Second, MnO 2 nanosheets have an intense and broad optical absorption spectrum (ca. 200-600 nm), making them an efficient broad-spectrum fluorescence quencher for the design of fluorescence turn-on probes for monitoring delivery efficiency.M ost importantly,M nO 2 nanosheets can react with intracellular glutathione (GSH), resulting in the disintegration of the nanosheets and hence complete release of photosensitizers for PDT.T his effectively depletes GSH, reducing its effects on 1 O 2 and enhancing PDT efficiency. Therefore,M nO 2 nanosheets provide ap otent and smart nanocarrier for both intracellular delivery of PDT agents and the reduction of intracellular GSH level to improve PDT efficiency.
Herein, we report ap hotosensitizer-MnO 2 nanosystem assembled by the physisorption of the commonly used photosensitizer chlorin e6 (Ce6) on MnO 2 nanosheets for highly efficient PDT, [32] [33] [34] as shown in Scheme 1. In this design, MnO 2 nanosheets act as ananocarrier for Ce6 and as an oxidant to reduce the level of intracellular GSH. Moreover, they were shown to efficiently quench the fluorescence of Ce6 to provide aturn-on fluorescence signal for monitoring delivery efficiency. In the Ce6-MnO 2 nanosystem, Ce6 is protected by MnO 2 from self-destruction upon light irradi-ation and can be efficiently delivered into cytoplasm. The nanosystem presents al ow fluorescence signal and low phototoxicity in the circulatory system. However,o nce endocytosed, the MnO 2 nanosheets are reduced by intracellular GSH. As ar esult, the nanosystem is disintegrated, simultaneously releasing Ce6 and decreasing the level of GSH for highly efficient PDT.M eanwhile,f luorescence recovery, accompanied by the dissolution of MnO 2 nanosheets,p rovides areporting signal for monitoring delivery efficiency.
It has been hypothesized that GSH can reduce PDT efficacy. To test this idea, we investigated the inhibitory effect of GSH on 1 Figure S1 ), demonstrating that GSH can easily deplete 1 O 2 and, as ar esult, reduce PDT efficacy. [35] Futhermore,o ther biomolecules were mixed separately with Ce6 and then irradiated. Thei ntroduction of these biomolecules (Supporting Information, Figure S2 ) induced negligible fluorescence intensity change of Ce6-incubated SOSG under irradiation, indicating that the consumption of 1 O 2 by GSH is highly specific in living systems.
To construct the Ce6-MnO 2 nanosystem, MnO 2 nanosheets were prepared by ultrasonicating bulk MnO 2 , [31] synthesized using H 2 O 2 to oxidize MnCl 2 in the presence of tetramethylammonium hydroxide,a nd identified by X-ray photoelectron spectroscopy and UV/Vis absorption with ap eak centered at 360 nm (Supporting Information, Figure S3 ). Ther esults from transmission electron microscopy indicated that as-prepared MnO 2 presented as heeted structure.N ext, we investigated the adsorption capacity of asprepared MnO 2 nanosheets for Ce6 photosensitizer by fluorescence analysis based on the excellent fluorescence quenching ability of MnO 2 nanosheets.D ifferent concentrations of MnO 2 nanosheets were mixed with 5 mm Ce6 (Supporting Information, Figure S4 ). MnO 2 nanosheets exhibited high quenching efficacy on Ce6. Fluorescence from Ce6 was completely quenched when the concentration of MnO 2 nanosheets was increased to 41.76 mgmL À1 .A tt hat concentration, the amount of adsorbed Ce6 on 1 mgo fa sprepared MnO 2 nanosheets was calculated to be about 120 nmol, demonstrating high Ce6 loading efficiency.F ollowing formation of the Ce6-MnO 2 nanosystem, 1 O 2 generation from Ce6 was then investigated. TheC e6-MnO 2 nanosystem presented much lower SOSG fluorescence intensity than that of free Ce6 (Supporting Information, Figure S5 ), demonstrating that MnO 2 nanosheets could efficiently inhibit SOG from Ce6 outside the cells and, hence,l imit the side effects of PDT. [36] TheCe6-MnO 2 nanosystem was then mixed with different concentrations of GSH to assess its ability to decompose the nanosystem. TheU V/Vis absorption band of MnO 2 nanosheets gradually decreased until it disappeared when the concentration of GSH increased from 0mm to 10 mm(Supporting Information, Figure S6 ), indicating that MnO 2 nanosheets were reduced to Mn 2+ ions by GSH. GSH-activated SOG from Ce6 was then investigated. With increasing GSH concentration, fluorescence from SOSG was enhanced accordingly (Supporting Information, Figure S7a ), indicating that Ce6 was released as MnO 2 nanosheets were decomposed. However,w hen the concentration of GSH was larger than 4mm,f luorescence from SOSG decreased dramatically,a s excess GSH could consume 1 O 2 via reduction, in good agreement with the results in the Supporting Information, Figure S1 . We then increased the concentration of MnO 2 to 522 mgmL À1 and tested the effect of 10 mm GSH on SOG. Fluorescence intensity from SOSG increased greatly (Supporting Information, Figure S7b ), indicating that plentiful MnO 2 could enhance PDT efficiencyofCe6 by decreasing the level of GSH.
Thed elivery efficacy of MnO 2 nanosheets was examined by comparing the internalization of the Ce6-MnO 2 nanosystem with that of free Ce6 in MCF-7 breast cancer cells.As shown by flow cytometry (Figure 1 ), MCF-7 cells treated with the Ce6-MnO 2 nanosystem showed significantly higher fluorescence intensity than those treated with free Ce6, indicating that the MnO 2 nanosheets could enhance the cellular uptake of Ce6 and release it efficiently.I na ddition, confocal laser scanning microscopy analysis of cells treated with the Ce6-MnO 2 nanosystem also presented much stronger fluorescence signals in cytoplasm than those treated with free Ce6, in good agreement with the results of flow cytometry.T hese results also demonstrated the Ce6-MnO 2 nanosystem was mainly distributed in the cytoplasm, and MnO 2 nanosheets were mainly reduced by the GSH in the cytoplasm. These data suggest that the MnO 2 nanosheets can efficiently deliver photosensitizer Ce6 into cells for photodynamic therapy.
To identify the phototoxicity of the Ce6-MnO 2 nanosystem, MTS assay (MTS = 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) was conducted for the nanosystem with and without irradiation with light. As shown in Figure 2a ,cell viability gradually Scheme 1. Activation mechanism of the Ce6-MnO 2 nanosystem for highly efficient photodynamic therapy.The nanosheet can adsorb and efficiently deliver photosensitizers into cells and protect them from self-destruction upon light irradiation.O nce endocytosed,t he nanosystem is disintegrated upon reduction of MnO 2 nanosheetsby intracellularGSH, simultaneously releasing Ce6f or fluorescence imaging and decreasing the level of GSH for highly efficient PDT.
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Zuschriften 5568 www.angewandte.de decreased with increasing concentration of Ce6 under irradiation. An anosystem containing 5 mm of Ce6 could induce 95 %o fc ell death. Without irradiation, however, only negligible cell death was observed with the nanosystem, indicating that the therapeutic effect was highly light-dependent. Moreover,M nO 2 nanosheets were found to have low cytotoxicity with concentration < 60 mgmL À1 (Supporting Information, Figure S9 ). In Figure 2b ,M CF-7 cells were treated with free Ce6 and Ce6-MnO 2 nanosystem with Ce6 at different concentrations,f ollowed by irradiation. With the same concentration of Ce6, free Ce6 showed minimal efficiency for PDT,w hile the Ce6-MnO 2 nanosystem was much more efficient. These results further demonstrated that MnO 2 nanocarriers could enhance the Ce6 uptake and result in the remarkably increased PDT efficacy.
Next, to investigate PDT efficacy of the Ce6-MnO 2 nanosystem in live cells,t he fluorescence and morphological changes of MCF-7 cells pretreated with Ce6-MnO 2 nanosystem and 405 nm laser irradiation (2 mW) were tracked in real time by confocal fluorescence imaging.A fter treatment with free Ce6 or Ce6-MnO 2 nanosystem for 4h,the cells were irradiated using the confocal microscope.U pon irradiation, cytoplasmic fluorescence gradually decreased in the first 2minutes with no significant morphological changes observed for the cells.A fter 3minutes irradiation, more and more bubbles appeared on the surface of cells,a nd the outer membrane was ruptured, but with little observable fluorescence signal, indicating obvious cell death (Figure 2c) . [37] In contrast, fluorescence and morphological changes of untreated cells (Supporting Information, Figure S8) were not observed under irradiation, demonstrating that the cell death in Figure 3c was induced by Ce6-based PDT,r ather than by the laser only.
To test the effect of GSH on PDTefficiency in cancer cells, we first used commercial agents to regulate the level of GSH. [31] Before incubating with Ce6 or the Ce6-MnO 2 nanosystem, MCF-7 cells were treated with a-lipoic acid (LPA, aG SH synthesis enhancer:5 00 mm)f or 24 ho r N-methylmaleimide (NMM, aG SH scavenger:2 mm)f or 20 min. Thecells were then incubated with free Ce6 and Ce6-MnO 2 containing different concentrations of Ce6. In parallel experiments (Supporting Information, Figure S10 ), we observed an absorbance enhancement at 490 nm for MCF-7 cells treated with LPA, while ad istinct decrease of absorbance was observed when MCF-7 cells were treated with NMM. Taken together,t hese results strongly support the influence of intracellular GSH on PDT.
To identify whether MnO 2 nanosheets have the capacity to improve the efficiencyo fP DT compared to other nanomaterials,g raphene oxide (GO), which presents as heeted 
Zuschriften structure like MnO 2 nanosheets,and mesoporous silica nanoparticles (MSN), which have high payload capacity,w ere introduced as controls (Supporting Information, Figure S11 ). As shown in Figure 3 , cells were treated with Ce6-GO and Ce6-MSN nanosystems with Ce6 at different concentrations. Both Ce6-GO and Ce6-MSN showed low PDT efficiency. Especially,w hen the concentration of Ce6 was increased to 5 mm,Ce6-GO and Ce6-MSN induced only 36 %and 21 %of cell death, respectively,while Ce6-MnO 2 induced 95 %ofcell death (Figure 2b ). These results demonstrated that Ce6-MnO 2 was much more efficient for PDT than other nanocarriers,w hich might be the synergistic effects of both high Ce6 release efficacya nd MnO 2 -induced GSH oxidation in cells.M nO 2 nanosheets could be reduced by intracellular GSH while GO and MSN could not, leading to the faster release of Ce6 on MnO 2 nanosheets than that of GO and MSN.Moreover,the self-quenching of Ce6 in them will result in poor PDT efficiency.
To further verify the effect of MnO 2 -induced GSH oxidation on the PDT efficacyo ft he nanosystem, free Ce6 at different concentrations and Ce6-MnO 2 nanosystem were incubated with cells separately.A ss hown in Figure 3c ,t he fluorescence intensity of cells treated with Ce6-MnO 2 nanosystem containing 1 mm of Ce6 is equal to that treated with 2 mm free Ce6, indicating that the amount of Ce6 released into the cells was about the same for these two treatments.F ree Ce6 and Ce6-MnO 2 nanosystem with a2:1 Ce6 concentration were then employed for further experiments.Under the same intracellular Ce6 concentration, Ce6-MnO 2 exhibited much higher PDT efficiency than that of free Ce6 (Supporting Information, Figure S12 ). This result together with the low cytotoxicity of free MnO 2 nanosheets (with concentration < 60 mgmL À1 )i ndicated that the MnO 2 -induced GSH oxidation could remarkably increase the efficiencyo fP DT.
Then we compared the cytotoxicity of the Ce6-MnO 2 nanosystem with that of free Ce6 at different concentrations. As shown in Figure 3d ,P DT efficiencyo ft he Ce6-MnO 2 nanosystem containing 2 mm Ce6 was nearly the same as that of 8 mm free Ce6. However,t he fluorescence intensities of cells treated with the Ce6-MnO 2 nanosystem was much weaker than that of cells treated with 8 mm free Ce6, as shown in Figure S13 , proving that MnO 2 nanosheets play both an anocarrier and aG SH scavenger role in Ce6-MnO 2 -induced phototoxicity.
To demonstrate the universality of the Ce6-MnO 2 nanosystem, PDT efficiencyo ft he nanosystem was further evaluated for various types of cells,s uch as HepG2 (liver cancer), HeLa (cervical cancer), A549 (lung cancer), MCF-7 (breast cancer) and 293T (Human embryonic kidney) cells. This nanosystem exhibited high PDT efficacyfor all cell lines (Supporting Information, Figure S14a) , with as lightly lower efficacyfor HepG2 cells and slightly higher efficacyfor 293T cells.T his difference may have resulted from the different GSH levels in these cell lines.T ov erify this hypothesis,w e further investigated intracellular GSH levels in different cell lines using confocal microscopy based on GSH-activated fluorescence recovery of Ce6, treating all cells with the Ce6-MnO 2 nanosystem at the same concentration (Supporting Information, Figure S14b ). Thea mount of the nanosystem present in cells was first analyzed by inductively coupled plasma optical emission spectrometry (ICP-OES). Experimental results (Supporting Information, Figure S15a) Figure S15b) , the average concentration of MnO 2 in MCF-7 cells was calculated to be about 2.53 mm based on the result of ICP-OES.T he local concentration of MnO 2 in cells would be much higher than 2.53 mm, which is sufficient to reduce intracellular GSH concentration. Taken together, these results indicate that the Ce6-MnO 2 nanosystem has broad applicability for killing different cell lines with PDT.
Thef easibility of in vivo PDT applications of the nanosystem was then verified by investigating the fate of Ce6 and Ce6-MnO 2 nanosystem using fluorescence imaging assay. Athymic nude mice with subcutaneous ZR-75-30 breast cancer xenografts were selected as the animal model. Ce6-MnO 2 nanosystem-treated ZR-75-30 cells resulted in apoptosis (Supporting Information, Figures S16 and S17). When the size of tumors reached about 60 mm 3 ,t he mice were intratumorally injected with 40 mLo fC e6 or 50 mLo fC e6-MnO 2 nanosystem, both containing 100 mm of Ce6. After intratumoral injection (Supporting Information, Figure S18a,b), fluorescence intensity of Ce6 in free Ce6-loaded tumors decreased gradually,w hile that in the Ce6-MnO 2 -loaded tumors increased in the first hour and then decreased gradually.T oe xplain these results,M nO 2 nanosheets were reduced gradually by intracellular GSH in the first hour,a ccounting for the recovery of Ce6 fluorescence. Thed ecreased fluorescence most likely resulted from the spread of Ce6 throughout the animals body.T hus,t he best timing for PDT is one hour after intratumoral injection.
In vivo therapeutic efficacyofCe6, MnO 2 nanosheets,and the Ce6-MnO 2 nanosystem was assessed by monitoring the growth rate of tumors.The sizes of tumors were normalized to their initial values. [38] Experimental results indicated that the free Ce6 and Ce6-MnO 2 nanosystem groups with light irradiation showed either remarkable delay in tumor growth or observable tumor regression compared with the control group treated with MnO 2 nanosheets after two weeks (Figure 4a) . In contrast, the groups without light irradiation showed no apparent change of tumor size compared with the control group,i ndicating that the therapeutic effect was highly light-dependent. It is noteworthy that the Ce6-MnO 2 nanosystem-treated group exhibited higher therapeutic efficacy compared with that of the free Ce6-or MnO 2 nanosheets-treated groups on day 12. Theweights of these mice in different groups in Figure 4b were in good agreement with the results of the growth rate of tumors.T hese results clearly demonstrated that enhanced PDT was achieved for the Ce6-MnO 2 nanosystem, which indicates that Ce6-MnO 2 nanosystem could both enhance Ce6 uptake in cells (need lower dose injection of PDT agent to decrease its side effect), and reduce GSH Levels in cells due to MnO 2 -induced GSH Angewandte Chemie Zuschriften 5570 www.angewandte.de oxidation. H&E staining of tumor sections was performed on day 12, and the results are shown in Figure 4c .I nP BS, histological sections of the MnO 2 -a nd Ce6-treated groups showed infiltrating tumor cells with highly pleomorphic nuclei and many mitoses,i ndicating limited benefit from laser treatment. These results indicate that the Ce6-MnO 2 nanosystem has excellent theranostic capability without noticeable toxicity and that it is suitable for imaging-guided PDT of tumors in vivo.
In summary,w eh ave developed as mart photosensitizerMnO 2 nanosystem with both high intracellular delivery efficiency and enhanced photodynamic therapy efficacyb y reducing glutathione levels in cancer cells.T his Ce6-MnO 2 nanosystem exhibits:1)high Ce6 loading efficiencyonMnO 2 nanosheets;2 )enhanced delivery of Ce6 into cells;a nd 3) simultaneous release of Ce6 and decrease of GSH level for highly efficient PDT.T he multifunctional MnO 2 nanosheets also show good biocompatibility,t hus facilitating their biomedical applications,p articularly for cancer theranostics. Therefore,t his smart Ce6-MnO 2 nanosystem shows high promise as af uture multifunctional treatment tool for simultaneous therapy and monitoring for various types of cancers. 
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